Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Titration Study of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR) in Preschool Children with Attention-Deficit/Hyperactivity Disorder

Preschool Children ◽

Attention Deficit ◽

Extended Release ◽

Dose Titration ◽

Double Blind ◽

Double Blind Placebo ◽

Hyperactivity Disorder ◽

Flexible Dose ◽

Titration Study

EPA-0666 – Long-term maintenance of efficacy of extended-release guanfacine hydrochloride (GXR) in children and adolescents with attention-deficit/hyperactivity disorder (ADHD): double-blind, placebo-controlled, multicentre, phase 3 randomized withdrawal study

European Psychiatry ◽

10.1016/s0924-9338(14)78034-4 ◽

2014 ◽

Vol 29 ◽

pp. 1 ◽

Cited By ~ 3

Author(s):

J. Newcorn ◽

V. Harpin ◽

M. Huss ◽

M. Johnson ◽

J.A. Ramos-Quiroga ◽

...

Keyword(s):

Attention Deficit ◽

Extended Release ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Multicentre Phase ◽

Hyperactivity Disorder ◽

Term Maintenance

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy, Safety, and Tolerability of Extended-Release Metadoxine in Adults With Attention-Deficit/Hyperactivity Disorder

The Journal of Clinical Psychiatry ◽

10.4088/jcp.12m07767 ◽

2012 ◽

Vol 73 (12) ◽

pp. 1517-1523 ◽

Cited By ~ 18

Author(s):

Iris Manor ◽

Rachel Ben-Hayun ◽

Judith Aharon-Peretz ◽

Dana Salomy ◽

Abraham Weizman ◽

...

Keyword(s):

Multicenter Study ◽

Attention Deficit ◽

Extended Release ◽

Double Blind ◽

Double Blind Placebo ◽

6.22 A Double-Blind, Placebo-Controlled, Dose-Ranging Study of Extended-Release Viloxazine (SPN-812 ER) in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1016/j.jaac.2017.09.367 ◽

2017 ◽

Vol 56 (10) ◽

pp. S283-S284

Author(s):

Janet K. Johnson ◽

Keith Saylor ◽

Scott T. Brittain ◽

Gabriela Tulloch ◽

Tesfaye Liranso

Keyword(s):

Attention Deficit ◽

Extended Release ◽

Double Blind ◽

Double Blind Placebo ◽

Hyperactivity Disorder ◽

Dose Ranging

Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: A 4-week, randomized, double-blind, placebo-controlled, parallel-group study

Clinical Therapeutics ◽

10.1016/j.clinthera.2006.02.011 ◽

2006 ◽

Vol 28 (2) ◽

pp. 266-279 ◽

Cited By ~ 64

Author(s):

Thomas J. Spencer ◽

Timothy E. Wilens ◽

Joseph Biederman ◽

Richard H. Weisler ◽

Stephanie C. Read ◽

...

Keyword(s):

Attention Deficit ◽

Extended Release ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Hyperactivity Disorder ◽

Parallel Group Study ◽

Parallel Group ◽

Adolescent Patients

Efficacy and Safety of Modafinil Film-Coated Tablets in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Study

PEDIATRICS ◽

10.1542/peds.2005-0617 ◽

2005 ◽

Vol 116 (6) ◽

pp. e777-e784 ◽

Cited By ~ 82

Author(s):

J. Biederman

Keyword(s):

Children And Adolescents ◽

Attention Deficit ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Hyperactivity Disorder ◽

Dose Study ◽

Flexible Dose

A Randomized, Double-Blind, Placebo-Controlled Study of HLD200, a Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder: An Evaluation of Safety and Efficacy Throughout the Day and Across Settings

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2019.0070 ◽

2020 ◽

Vol 30 (1) ◽

pp. 2-14 ◽

Cited By ~ 2

Author(s):

Ann C. Childress ◽

Andrew J. Cutler ◽

Andrea Marraffino ◽

Mary Ann McDonnell ◽

John M. Turnbow ◽

...

Keyword(s):

Attention Deficit ◽

Extended Release ◽

Controlled Study ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo ◽

Hyperactivity Disorder ◽

Delayed Release

Short-Term Side Effects of Stimulant Medication Are Increased in Preschool Children with Attention-Deficit/Hyperactivity Disorder: A Double-Blind Placebo-Controlled Study

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.1998.8.13 ◽

1998 ◽

Vol 8 (1) ◽

pp. 13-25 ◽

Cited By ~ 61

Author(s):

PHILIP FIRESTONE ◽

LYNETTE MONTEIRO MUSTEN ◽

SUSAN PISTERMAN ◽

JOHN MERCER ◽

SUSAN BENNETT

Keyword(s):

Preschool Children ◽

Side Effects ◽

Attention Deficit ◽

Stimulant Medication ◽

Controlled Study ◽

Short Term ◽

Double Blind ◽

Double Blind Placebo ◽

6.42 A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED MULTICENTER STUDY MEASURING THE EFFICACY AND SAFETY OF A NOVEL, EXTENDED-RELEASE FORMULATION OF METHYLPHENIDATE (PRC-063) IN ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1016/j.jaac.2016.09.362 ◽

2016 ◽

Vol 55 (10) ◽

pp. S217-S218 ◽

Cited By ~ 1

Author(s):

Scott H. Kollins ◽

Andrew J. Cutler ◽

Sohail Khattak ◽

Margaret D. Weiss ◽

Graeme Donnelly ◽

...

Keyword(s):

Multicenter Study ◽

Attention Deficit ◽

Extended Release ◽

Efficacy And Safety ◽

Double Blind ◽

Release Formulation ◽

Double Blind Placebo ◽

Extended Release Formulation ◽

Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder

CNS Drugs ◽

10.1007/s40263-017-0468-2 ◽

2017 ◽

Vol 31 (11) ◽

pp. 999-1014 ◽

Cited By ~ 13

Author(s):

Jeffrey H. Newcorn ◽

Peter Nagy ◽

Ann C. Childress ◽

Glen Frick ◽

Brian Yan ◽

...

Keyword(s):

Attention Deficit ◽

Extended Release ◽

Double Blind ◽

Double Blind Placebo ◽

A Randomized, Double-Blind, Placebo-Controlled Study of Guanfacine Extended Release in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

PEDIATRICS ◽

10.1542/peds.2006-3695 ◽

2008 ◽

Vol 121 (1) ◽

pp. e73-e84 ◽

Cited By ~ 202

Author(s):

J. Biederman ◽

R. D. Melmed ◽

A. Patel ◽

K. McBurnett ◽

J. Konow ◽

...

Keyword(s):

Children And Adolescents ◽

Attention Deficit ◽

Extended Release ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽